Alveo Technologies Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Alveo Technologies's estimated annual revenue is currently $11.2M per year.(i)
  • Alveo Technologies's estimated revenue per employee is $155,000

Employee Data

  • Alveo Technologies has 72 Employees.(i)
  • Alveo Technologies grew their employee count by 0% last year.

Alveo Technologies's People

NameTitleEmail/Phone
1
Founder and CEOReveal Email/Phone
2
CFOReveal Email/Phone
3
CEO and ChairmanReveal Email/Phone
4
VP Quality AssuranceReveal Email/Phone
5
VP, Portfolio Planning and Program ManagementReveal Email/Phone
6
VP, Research & Development OperationsReveal Email/Phone
7
ControllerReveal Email/Phone
8
VP Software EngineeringReveal Email/Phone
9
VP Clinical AffairsReveal Email/Phone
10
Senior Director, People & CultureReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Alveo Technologies?

In today's interconnected world, we are currently faced with many global challenges and opportunities surrounding infectious diseases. At Alveo, we're tackling these head-on by creating technology platforms that provide rapid, reliable, and economical cloud-based diagnostics for use by everyone, anytime, everywhere.

keywords:N/A

N/A

Total Funding

72

Number of Employees

$11.2M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Alveo Technologies News

2022-04-06 - AMD: Pensando gives us better-than-AWS networking tech to rule the cloud

The application of the technology is way beyond that," he said. ... company that is using both Pensando and Alveo technologies concurrently.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$19.9M971%N/A
#2
$19.4M1084%N/A
#3
$30.5M1138%N/A
#4
$33.9M11316%$96M
#5
$20.9M116205%N/A